New solution for therapeutic cancer vaccine failure

submitted by: mdanderson
http://www.mdanderson.org/newsroom/news-releases/2013/cancer-vaccines-ch... Vaccines designed to turn the immune system against cancer have been logically constructed and tested against many cancers. Almost all have failed or shown minimal effect. They spark creation of killer T cells against the cancer, but generally have little effect on tumors, both in patients and mouse models. Willem Overwijk, Ph.D., and colleagues at MD Anderson discovered that a common vaccine component is...

Science Nation - Early Cancer Screening

submitted by: nsf
With few early symptoms, ovarian cancer — like many cancers — can be hard to detect without invasive and expensive procedures. "Early detection is absolutely not only key but probably the only way for us to win the war on cancer," says Vadim Backman who is a biomedical engineer at Northwestern University in Evanston, Ill. With support from the National Science Foundation, in part funded through the American Recovery and Reinvestment Act of 2009 (ARRA), Backman's research is shedding...

Science Nation - Body Rhythms and Breast Cancer

submitted by: nsf
Could working the night shift alter a woman's body clock enough to cause breast cancer? "One minute you're a healthy person, the next minute you have breast cancer." Ettamay (last name withheld) is up early these days. She lives a much different life than she did when she was a nurse working the night shifts. She would be just getting to sleep at this early morning hour. "I was always exhausted," she says. "I don't know any of the nurses, especially the night shift gals, that weren't...

Cancer Research for Stage 1 Lung Cancer

submitted by: mdanderson

New cancer research for stage 1 lung cancer is being investigated at The University of Texas MD Anderson Cancer Center. It’s led by Jack Roth, M.D., professor in the Department of Thoracic and Cardiovascular Surgery. This clinical trial called STARS (Stereotactic Radiation Therapy Verses Surgery) compares a new type of radiation treatment with a traditional surgery approach. Roth describes this promising new treatment and explains how lung cancer patients may get involved.

Ronald DePinho, M.D., on the future of cancer treatment and research

submitted by: mdanderson
http://bit.ly/k9A2zm In this clip, MD Anderson president-designate Ronald DePinho, M.D., gives his thoughts on the future of cancer treatment and research. The University of Texas System Board of Regents today (June 9) named Ronald A. DePinho, M.D., president of the UT MD Anderson Cancer Center in Houston. The Board announced Dr. DePinho, a Harvard professor and cancer institute administrator, as president following a special called meeting of regents. Dr. DePinho had been named the sole...

Bioinformatics Insight

submitted by: capino

Introduction to bioinformatics with Dr. Steve Jones, Head, Bioinformatics, Genome Sciences Centre, BC Cancer Agency